3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
4
Brain Neoplasms
4
Oligodendroglioma
3
Gliosarcoma
3
Glioma
3
Glioblastoma
3
Ependymoma
3
Astrocytoma
3
Pinealoma
2
Neuroectodermal Tumors, Primitive
2
Neoplasms
2
Meningioma
2
Medulloblastoma
2
Choroid Plexus Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Glioma, Subependymal
1
Craniopharyngioma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
340
Cisplatin
238
Paclitaxel
203
Radiotherapy
195
Pemetrexed
187
Docetaxel
169
Gemcitabine
157
pembrolizumab
141
Erlotinib Hydrochloride
107
Etoposide
99
Magnetic Resonance Spectroscopy
93
Bevacizumab
91
Specimen Handling
76
Nivolumab
73
Radiosurgery
72
durvalumab
69
Vinorelbine
54
osimertinib
53
Gefitinib
49
Drug Therapy
49
atezolizumab
42
Irinotecan
42
Radiation
40
Topotecan
39
Biopsy
39
Standard of Care
38
Cyclophosphamide
38
Cetuximab
35
Blood Specimen Collection
33
Taxes
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lung Neoplasms
×
Gadolinium DTPA
×
Clear all
NCT01047059
2016-05-20
MIMEB
University of Cologne
Phase 2
Completed
40 enrolled